Chicago, Illinois 60614


This study aims to show that the MedGem indirect calorimetry measurement device will be feasible to use in children with GVHD. Also, it aims to show that children with chronic GVHD will have elevated REE that is not adequately predicted by standard equations.

Study summary:

Chronic Graft versus Host Disease (GVHD) is an important cause of morbidity and mortality in patients undergoing allogeneic bone marrow and hematopoietic progenitor cell transplantation. In adults, it has been shown that patients with acute or chronic GVHD have an increase in their resting energy expenditure (REE), likely as a result of chronic systemic inflammation. These studies have not yet been performed in children. This study's objective is to determine the REE of pediatric patients with acute and chronic GVHD after hematopoietic stem cell transplantation (HSCT).


Inclusion Criteria: - Subjects must be 7-30 years of age - Signed informed consent - One of the following three criteria must be met: - Presence of grade II or greater acute GVHD as defined by Keystone criteria - Presence of clinically extensive chronic GVHD as defined by the revised Seattle criteria - Any subject identified prior to allogeneic transplant, or following allogeneic transplant, who is at risk for acute or chronic GVHD Exclusion Criteria: - Inability to meet the requirements of the study procedures - Any subject who is receiving supplemental oxygen - Withdrawal of consent



Primary Contact:

Principal Investigator
Morris Kletzel, MD
Children's Memorial Hospital

Morris Kletzel, MD
Phone: 773-880-4562

Backup Contact:

Meredith Marshall
Phone: 773-880-3459

Location Contact:

Chicago, Illinois 60614
United States

There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source:

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.